Rise and shine, everyone. Another busy day is on the way. And you know what that means - a long to-do list filled with meetings and deadlines and what-not. So time to get cracking, and what better way to begin than with a cup of needed stimulation? So far this week, our choice has been Wild Mountain Blueberry. Feel free to join us, of course. Meanwhile, here is another batch of tidbits we hope you find useful. Have a great day and do stay in touch...
Abbott Spinoff Falls On 'When Issued' Trading Basis (Bloomberg News)
India Revokes Merck Patent On Asthma Drug (Reuters)
KV Pharma To Pay $60M To Settle Makena Dispute (St. Louis Business Today)
Boehringer Sued By Hundreds Over Pradaxa Bleeding Risk (Bloomberg News)
Swiss Police Say Leak At Novartis Plant Hurts Six Workers (Reuters)
Compounder Behind Meningitis Outbreak Pushed Hard To Expand (CNBC)
J&J's Zytiga Wins FDA OK For Early Prostate Cancer Use (Bloomberg News)
Novo Bets On Turning Victoza Into Obesity Blockbuster (Reuters)
Acura Debuts Abuse-Resistance Decongestant (Associated Press)
Pfizer Asks Supreme Court To Nix Bankruptcy-Related Asbestos Suits (Reuters)
Teva Stock Gains As Investor Meeting Nears (Bloomberg News)
Glaxo And Vodafone Work To Boost Vaccine Use In Africa (Pharma Times)
Novartis Says Tasigna Is Better Than Gleevec For CML (Reuters)
EDITOR'S NOTE: Please check this post for updates
sunshine pic thx to benimoto on flickr